Literature DB >> 20660366

KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.

Sung Jin Huh1, Yen-Liang Chen, Scott L Friedman, Jason Liao, H-J Su Huang, Webster K Cavenee, Gavin P Robertson.   

Abstract

BACKGROUND: A putative tumor suppressor gene at chromosome 10p15, which contains KLF6 and other genes, is predicted to be lost during melanoma development, and its identity is unknown. In this study, we investigated the biological roles and identity of this tumor suppressor gene.
METHODS: The human UACC 903 melanoma cell line containing introduced DNA fragments from the 10p15 region with (10E6/3, 10E6/11, and 10E6/18) and without (10ER4S.2/1) the tumor suppressor gene was used. Xenograft tumors were generated in a total of 40 mice with melanoma cell lines, and tumor size was measured. Cells were cultured on plastic or a gel of type I collagen. Viability, proliferation, and apoptosis were assessed. Expression of KLF6 protein was assessed by immunohistochemistry and immunoblot analysis. Expression of phosphorylated Erk1/2 and cyclin D1 was assessed by immunoblot analysis. Protein expression of KLF6 was inhibited with small interfering RNA (siRNA). KLF6 protein expression was assessed in 17 human nevi and human melanoma specimens from 29 patients. Statistical analyses were adjusted for multiple comparisons by use of Dunnett method. All statistical tests were two-sided.
RESULTS: Melanoma cells containing KLF6 generated smaller subcutaneous xenograft tumors with fewer proliferating cells than control cells. When grown on collagen 1, viability of cells with ectopic KLF6 expression (72%) was lower than that of control cells (100%) (group difference = -28%, 95% confidence interval = -31.3% to -25.2%, P < .001). Viability of melanoma cells with or without the KLF6 tumor suppressor gene on plastic dishes was similar. When KLF6 expression was inhibited with KLF6 siRNA, viability of cells with the tumor suppressor gene on collagen I gel increased compared with that of control cells carrying scrambled siRNA. KLF6 protein was detected in all nevi examined but not in human metastatic melanoma tissue examined. Ectopic expression of KLF6 protein in melanoma cells grown on collagen I decreased levels of phosphorylated Erk1/2 and cyclin D1 in the mitogen-activated protein kinase signaling pathway.
CONCLUSIONS: In melanoma cells, the tumor suppressor gene at 10p15 appears to be KLF6. Signaling from the collagen I-rich extracellular matrix appears to be involved in the tumor suppressive activity of KLF6 protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660366      PMCID: PMC2914760          DOI: 10.1093/jnci/djq218

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  53 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.

Authors:  Meenhard Herlyn; Martin Padarathsingh; Lynda Chin; Mary Hendrix; Dorothea Becker; Mark Nelson; Yves DeClerck; James McCarthy; Suresh Mohla
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 3.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

4.  Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

Authors:  Kevin B Hotary; Edward D Allen; Peter C Brooks; Nabanita S Datta; Michael W Long; Stephen J Weiss
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

5.  Rigidity of collagen fibrils controls collagen gel-induced down-regulation of focal adhesion complex proteins mediated by alpha2beta1 integrin.

Authors:  Yang-Kao Wang; Yao-Hsien Wang; Chau-Zen Wang; Junne-Ming Sung; Wen-Tai Chiu; Shu-Han Lin; Yung-Hen Chang; Ming-Jer Tang
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

Review 6.  PTEN signaling pathways in melanoma.

Authors:  Heng Wu; Vikas Goel; Frank G Haluska
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

7.  Loss of PTEN promotes tumor development in malignant melanoma.

Authors:  Jill M Stahl; Mitchell Cheung; Arati Sharma; Nishit R Trivedi; Sumathi Shanmugam; Gavin P Robertson
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

Review 8.  Remodeling of the microenvironment by aggressive melanoma tumor cells.

Authors:  Mary J C Hendrix; Elisabeth A Seftor; Dawn A Kirschmann; Vito Quaranta; Richard E B Seftor
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

Review 10.  Sp1- and Krüppel-like transcription factors.

Authors:  Joanna Kaczynski; Tiffany Cook; Raul Urrutia
Journal:  Genome Biol       Date:  2003-02-03       Impact factor: 13.583

View more
  6 in total

Review 1.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

2.  Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.

Authors:  Lara Grande; Gabriel Bretones; Manuel Rosa-Garrido; Eva M Garrido-Martin; Teresa Hernandez; Susana Fraile; Luisa Botella; Enrique de Alava; August Vidal; Xavier Garcia del Muro; Alberto Villanueva; M Dolores Delgado; Jose L Fernandez-Luna
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

Review 3.  Current and future trials of targeted therapies in cutaneous melanoma.

Authors:  Matthew S Evans; Subbarao V Madhunapantula; Gavin P Robertson; Joseph J Drabick
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.

Authors:  SubbaRao V Madhunapantula; Arati Sharma; Raghavendra Gowda; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2013-09-19       Impact factor: 4.693

5.  Uncover disease genes by maximizing information flow in the phenome-interactome network.

Authors:  Yong Chen; Tao Jiang; Rui Jiang
Journal:  Bioinformatics       Date:  2011-07-01       Impact factor: 6.937

6.  Loss of ADAM9 Leads to Modifications of the Extracellular Matrix Modulating Tumor Growth.

Authors:  Anna N Abety; Elke Pach; Nives Giebeler; Julia E Fromme; Lavakumar Reddy Aramadhaka; Cornelia Mauch; Jay W Fox; Paola Zigrino
Journal:  Biomolecules       Date:  2020-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.